Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation

Cited by (364)

Items 101–200 of 364

1. Molecules that Target beta‐Amyloid
   Cliff I. Stains, Kalyani Mondal, Indraneel Ghosh · 2007 · ChemMedChem
2. Back to the Future with Phenotypic Screening
   Marguerite Prior, Chandramouli Chiruta, Antonio Jose Martins Currais, Josh Goldberg, Justin Ramsey, Richard Dargusch, Pamela A Maher, David A. Schubert · 2014 · ACS Chemical Neuroscience
3. Dissociating β-Amyloid from α7 Nicotinic Acetylcholine Receptor by a Novel Therapeutic Agent, S 24795, Normalizes α7 Nicotinic Acetylcholine and NMDA Receptor Function in Alzheimer's Disease Brain
   Hoau-Yan Wang, Andres Stucky, Jingjing Liu, Changpeng Shen, C. Trocmé, Philippe Morain · 2009 · Journal of Neuroscience
4. Peptides, Peptidomimetics, and Carbohydrate–Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer’s Disease
   Philip Ryan, Bhautikkumar Patel, Vivek Makwana, Hemant R. Jadhav, Milton J. Kiefel, Andrew Keith Davey, Tristan A. Reekie, Santosh Rudrawar, Michael Kassiou · 2018 · ACS Chemical Neuroscience
5. Amyloid-β-(1-42) Increases Ryanodine Receptor-3 Expression and Function in Neurons of TgCRND8 Mice
   Charlene B Supnet, Jeff Grant, Hong Kong, David A. Westaway, Michael B. Mayne · 2006 · Journal of Biological Chemistry
6. Animal models of dementia and cognitive dysfunction
   Neha Neha, Rupinder Kaur Sodhi, Amteshwar Singh Jaggi, Nirmal Singh · 2014 · Life Sciences
7. Quantitative histological analysis of amyloid deposition in Alzheimer’s double transgenic mouse brain
   Thomas M. Wengenack, Shelly L. Whelan, Geoffry L. Curran, Karen Duff, Joseph F. Poduslo · 2000 · Neuroscience
8. An Update of Animal Models of Alzheimer Disease with a Reevaluation of Plaque Depositions
   Jung Eun Lee, Pyung‐Lim Han · 2013 · Experimental Neurobiology
9. Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy
   Robert Nisticò, Marco Pignatelli, Sonia Piccinin, Nicola Biagio Mercuri, Graham L. Collingridge · 2012 · Molecular Neurobiology
10. Drastic neuronal loss in vivo by β-amyloid racemized at Ser26 residue: conversion of non-toxic [D-Ser26]β-amyloid 1–40 to toxic and proteinase-resistant fragments
    Isamu Kaneko, K Morimoto, T Kubo · 2001 · Neuroscience
11. Glutamate and Mitochondria: Two Prominent Players in the Oxidative Stress-Induced Neurodegeneration
    Tommaso Cassano, Lorenzo Pace, Gaurav Bedse, Angelo Michele Lavecchia, Federico De Marco, Silvana Gaetani, Gaetano Serviddio · 2015 · Current Alzheimer Research
12. Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice
    Katrin Schüssel, Claudia Frey, Claudia Jourdan, Uta Keil, Claudia C. Weber, Franz Müller-Spahn, Walter E. Müller, Anne Eckert · 2005 · Free Radical Biology and Medicine
13. ApoE and Aβ1–42 Interactions: Effects of Isoform and Conformation on Structure and Function
    Manelli, Arlene M., Stine, W. Blaine, Van Eldik, Linda J., LaDu, Mary Jo · 2004 · Journal of Molecular Neuroscience
14. Adult neurogenesis is functionally associated with AD-like neurodegeneration
    Qian Chen, Akira Nakajima, Se Hoon Choi, Xiaoli Xiong, Sangram S. Sisodia, Ya‐Ping Tang · 2007 · Neurobiology of Disease
15. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease
    Wei Zhang, Jian Hao, Rui Liu, Zhuo Zhang, Gesheng Lei, Changjun Su, Jianting Miao, Zhuyi Li · 2011 · Behavioural Brain Research
16. Intraneuronal Aβ immunoreactivity is not a predictor of brain amyloidosis-β or neurofibrillary degeneration
    Jerzy Węgiel, Izabela Kuchna, Krzysztof Nowicki, Janusz Frackowiak, Bozena Mazur‐Kolecka, Humi Imaki, Jarek Wegiel, Pankaj D Mehta, Wayne P. Silverman, ‌Barry Reisberg et al. · 2007 · Acta Neuropathologica
17. The impact of Aβ-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice
    Hu, L, Wong, T.P, Côté, S.L, Bell, K.F.S, Cuello, A.C · 2003 · Neuroscience
18. Development of a safe oral Aβ vaccine using recombinant adeno-associated virus vector for Alzheimer's disease
    Hideo Hara, Alon Monsonego, Katsutoshi Yuasa, Kayo Adachi, Xiao Xiao, Shin’ichi Takeda, Keikichi Takahashi, Howard L. Weiner, Takeshi Tabira · 2004 · Journal of Alzheimer s Disease
19. A Unifying Hypothesis of Alzheimer's Disease. IV. Causation and Sequence of Events
    K. Heininger · 2000 · Reviews in the Neurosciences
20. Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 Transgenes
    Mustafa Ayberk Kurt, D. Ceri Davies, M. Kidd, Karen Duff, S.C. Rolph, Kevin H. JENNINGS, David R Howlett · 2001 · Experimental Neurology
21. Mechanism of Neuronal versus Endothelial Cell Uptake of Alzheimer's Disease Amyloid β Protein
    Kandimalla, Karunya K., Scott, Olenych G., Fulzele, Smita, Davidson, Michael W., Poduslo, Joseph F. · 2009 · PLoS ONE
22. Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes
    Christopher Janus, S D’Amelio, Oren Aaron Amitay, Muhammad Azhar Chishti, Robert Strome, P Fraser, George A. Carlson, John Roder, Peter St George‐Hyslop, David A. Westaway · 2000 · Neurobiology of Aging
23. Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents Aβ25–35-induced reduction in BPRP in PC12 cells
    Yan-Hua Lin, Ai-Hua Liu, Hongli Wu, Christel Westenbroek, Qianliu Song, He-Ming Yu, Gert J. Ter Horst, Xue-Jun Li · 2006 · Biochemical and Biophysical Research Communications
24. Distinct temporal and anatomical distributions of amyloid-β and tau abnormalities following controlled cortical impact in transgenic mice
    Tran, Hien T., Sanchez, Laura, Esparza, Thomas J., Brody, David L. · 2011 · PLoS ONE
25. Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of the amyloid‐β peptide
    Isabelle Sponne, Alexandre Fifre, Badreddine Kriem, Violette Koziel, Bernard E. Bihain, Thierry Oster, J L Olivier, Thierry Pillot · 2004 · The FASEB Journal
26. Aβ42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease
    Mochizuki, Akihide, Tamaoka, Akira, Shimohata, Atsushi, Komatsuzaki, Yasuko, Shoji, Shin'ichi · 2000 · The Lancet
27. O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease
    Philip Ryan, Mingming Xu, Andrew Keith Davey, Jonathan J. Danon, George D. Mellick, Michael Kassiou, Santosh Rudrawar · 2019 · ACS Chemical Neuroscience
28. Early intraneuronal Aβ deposition in the hippocampus of APP transgenic mice
    Feng‐Shiun Shie, Renée C. LeBoeur, Lee‐Way Jin · 2003 · Neuroreport
29. Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events
    Tenner, A · 2001 · Neurobiology of Aging
30. Alzheimer Aβ Peptide Induces Chromosome Mis-Segregation and Aneuploidy, Including Trisomy 21: Requirement for Tau and APP
    Antoneta Granic, Jaya Padmanabhan, Michelle Norden, Huntington Potter · 2009 · Molecular Biology of the Cell
31. Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex
    Lindsay A. Welikovitch, Sonia Do Carmo, Zsófia Maglóczky, Péter Szocsics, János Lőke, Tamás F. Freund, A. Claudio Cuello · 2018 · Acta Neuropathologica
32. Glypican‐1 as an Aβ binding HSPG in the human brain: Its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease
    Norifumi Watanabe, Wataru Araki, Dehua Chui, Takao Makifuchi, Yasuo Ihara, Takeshi Tabira · 2004 · The FASEB Journal
33. Secretion and Intracellular Generation of Truncated Aβ in β-Site Amyloid-β Precursor Protein-cleaving Enzyme Expressing Human Neurons
    Edward B. Lee, Daniel Skovronsky, Farhad Abtahian, Robert W. Doms, Virginia M.‐Y. Lee · 2003 · Journal of Biological Chemistry
34. Presenilin transgenic mice as models of Alzheimer’s disease
    Gregory A. Elder, Miguel A. Gama Sosa, Rita De Gasperi, Dara L. Dickstein, Patrick R. Hof · 2009 · Brain Structure and Function
35. Death and survival of neuronal cells exposed to Alzheimer's insults
    Takako Niikura, Yuichi Hashimoto, Hirohisa Tajima, Ikuo Nishimoto · 2002 · Journal of Neuroscience Research
36. Discovery and development of biomarkers of neurological disease
    Travis L. Dunckley, Keith D. Coon, Dietrich A. Stephan · 2005 · Drug Discovery Today
37. Intracellular A-Beta Amyloid, A Sign for Worse Things to Come?
    Valentina Echeverrı́a, A. Claudio Cuello · 2002 · Molecular Neurobiology
38. Presenilin 1 Suppresses the Function of C-Jun Homodimers via Interaction with Qm/Jif-1
    Ichiro Imafuku, Toshihiro Masaki, Masaaki Waragai, S. Takeuchi, Masahiro Kawabata, S Hirai, Shigeo Ohno, Linda E. Nee, Carol Frances Lippa, Ichiro Kanazawa et al. · 1999 · The Journal of Cell Biology
39. Rodent Models of Amyloid-Beta Feature of Alzheimer’s Disease: Development and Potential Treatment Implications
    Chi Him Poon, Yingyi Wang, Man‐Lung Fung, Chengfei Zhang, Lee Wei Lim · 2020 · Aging and Disease
40. Phospholipid–Protein Structured Membrane for Microencapsulation of DHA Oil and Evaluation of Its In Vitro Digestibility: Inspired by Milk Fat Globule Membrane
    Ying Chen, Hui Min Ge, Yan Zheng, Hong Zhang, Ye Li, Xiurong Su, Worawan Panpipat, Oi Ming Lai, Chin Ping Tan, Ling‐Zhi Cheong · 2020 · Journal of Agricultural and Food Chemistry
41. Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice
    Oster, Thierry, Pillot, Thierry · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
42. Overexpression of Neprilysin Reduces Alzheimer Amyloid-β42 (Aβ42)-induced Neuron Loss and Intraneuronal Aβ42 Deposits but Causes a Reduction in cAMP-responsive Element-binding Protein-mediated Transcription, Age-dependent Axon Pathology, and Premature Death in Drosophila
    Kanae Iijima‐Ando, Stephen Hearn, Linda Granger, Christopher Shenton, Anthony Gatt, Hsueh‐Cheng Chiang, Inessa Hakker, Yi Zhong, Koichi Iijima · 2008 · Journal of Biological Chemistry
43. Alzheimer's presenilin 1 causes chromosome missegregation and aneuploidy
    Debrah I. Boeras, Antoneta Granic, Jaya Padmanabhan, Nichole C. Crespo, Amyn M. Rojiani, Huntington Potter · 2006 · Neurobiology of Aging
44. Isolation and Characterization of Novel Presenilin Binding Protein
    Atsushi Kashiwa, Hirotaka Yoshida, Soon Lee, Toni Paladino, Yuanbin Liu, Qi Chen, Richard Dargusch, David A. Schubert, Hideo Kimura · 2000 · Journal of Neurochemistry
45. Modulation of 5-Lipoxygenase in Proteotoxicity and Alzheimer's Disease
    Elvira Valera, Richard Dargusch, Pamela A Maher, David Schubert · 2013 · Journal of Neuroscience
46. β-Amyloid Racemized at the Ser26Residue in the Brains of Patients with Alzheimer Disease: Implications in the Pathogenesis of Alzheimer Disease
    Takekazu Kubo, Yoshihiro Kumagae, Carol A. Miller, Isao Kaneko · 2003 · Journal of Neuropathology & Experimental Neurology
47. Introduction of pathogenic mutations into the mouse Psen1 gene by Base Editor and Target-AID
    Hiroki Sasaguri, Kenichi Nagata, Misaki Sekiguchi, Ryo Fujioka, Yukio Matsuba, Shoko Hashimoto, Kaori Sato, Deepika Kurup, Takanori Yokota, Takaomi C. Saido · 2018 · Nature Communications
48. Altered apolipoprotein D expression in the brain of patients with Alzheimer disease
    B. Belloir, Enikò Kövari, Maria Surini, Armand Savioz · 2001 · Journal of Neuroscience Research
49. Rab5 Mediates an Amyloid Precursor Protein Signaling Pathway That Leads to Apoptosis
    Daphna Laifenfeld, Lucas J. Patzek, Donna L. McPhie, Yuzhi Chen, Yona Levites, Anne M. Cataldo, Rachael L. Neve · 2007 · Journal of Neuroscience
50. The Molecular Pathology of Alzheimer's Disease
    Charles R. Harrington · 2012 · Neuroimaging Clinics of North America
51. Argyrophilic dark neurons represent various states of neuronal damage in brain insults: some come to die and others survive
    Kazuto Ishida, Hideo Shimizu, Hideki Hida, Susumu Urakawa, K Ida, H Nishino · 2004 · Neuroscience
52. Amyloid and Alzheimer's Disease: Inside and Out
    Joshua H. K. Tam, Stephen Pasternak · 2012 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
53. The essential role of lipids in Alzheimer's disease
    Sabrina Florent‐Béchard, Cédric Desbène, Pierre Garcia, Ahmad Allouche, Ihsen Youssef, Marie‐Christine Escanyé, Violette Koziel, Marine Hanse, Catherine Malaplate, Christophe Stenger et al. · 2009 · Biochimie
54. Understanding the molecular basis of Alzheimer’s disease using a Caenorhabditis elegans model system
    Collin Y. Ewald, Chris Li · 2009 · Brain Structure and Function
55. Alzheimer Aβ disrupts the mitotic spindle and directly inhibits mitotic microtubule motors
    Sergiy I. Borysov, Antoneta Granic, Jaya Padmanabhan, Claire Walczak, Huntington Potter · 2011 · Cell Cycle
56. The Place of Choline Acetyltransferase Activity Measurement in the “Cholinergic Hypothesis” of Neurodegenerative Diseases
    Antonio Contestabile, Elisabetta Ciani, Andrea Contestabile · 2007 · Neurochemical Research
57. Intraneuronal amyloid β and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease
    Van Broeck, Bianca, Vanhoutte, Greet, Pirici, Daniel, Van Dam, Debby, Wils, Hans, Cuijt, Ivy, Vennekens, Krist’l, Zabielski, Monika, Michalik, Andrej, Theuns, Jessie et al. · 2008 · Neurobiology of Aging
58. Magnesium Modulates Amyloid-β Protein Precursor Trafficking and Processing
    Jia Hui Yu, Miao Sun, Zheng Chen, Jiangyang Lu, Yi Liu, Liang Zhou, Xuemin Xu, Dongsheng Fan, Dehua Chui · 2010 · Journal of Alzheimer s Disease
59. Modeling Alzheimer’s disease: from past to future
    Claudia Saraceno, Stefano Musardo, Elena E. Marcello, Silvia Pelucchi, Mónica Di Luca · 2013 · Frontiers in Pharmacology
60. Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice
    Robert B. Amson, Jean‐Michel Lassalle, Hélène Halley, Sylvie Prieur, Florence Lethrosne, Jean-Pierre Roperch, David Israeli, Marie‐Claude Gendron, Charles J. Duyckaerts, Frédéric Checler et al. · 2000 · Proceedings of the National Academy of Sciences
61. Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?
    Frédéric Checler, Elissa Afram, Raphaëlle Pardossi‐Piquard, Inger Lauritzen · 2021 · Journal of Biological Chemistry
62. Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations
    Silke Leutner, Christian Czech, Katharina Schindowski, Nathalie Touchet, Anne Eckert, Walter E Müller · 2000 · Neuroscience Letters
63. Significance of intracellular A beta 42 accumulation in Alzheimer s disease
    Takeshi Tabira · 2002 · Frontiers in bioscience
64. Metabonomic Profiling of TASTPM Transgenic Alzheimer’s Disease Mouse Model
    Zeping Hu, Edward R. Browne, Tao Liu, Thomas E. Angel, Paul C. Ho, Eric Chun Yong Chan · 2012 · Journal of Proteome Research
65. Presynaptic Defects Underlying Impaired Learning and Memory Function in Lipoprotein Lipase-Deficient Mice
    Xunde Xian, Tingting Liu, Jia Hui Yu, Yuhui Wang, Yifei Miao, Jianjun Zhang, Yan Yu, Colin J. Ross, Joanna M. Karasinska, Michael R. Hayden et al. · 2009 · Journal of Neuroscience
66. Design of β-Amyloid Aggregation Inhibitors from a Predicted Structural Motif
    Paul A. Novick, Dahabada H. J. Lopes, Kim Branson, Alexandra Esteras‐Chopo, Isabella A. Graef, Gal Bitan, Vijay S. Pande · 2012 · Journal of Medicinal Chemistry
67. Protein aging hypothesis of Alzheimer disease
    Józef Orpiszewski, Norbert Schormann, Barbara Kluve‐Beckerman, Juris J. Liepnieks, Merrill D. Benson · 2000 · The FASEB Journal
68. Effects of Neprilysin Chimeric Proteins Targeted to Subcellular Compartments on Amyloid β Peptide Clearance in Primary Neurons
    Emi Hama, Keiro Shirotani, Nobuhisa Iwata, Takaomi C. Saido · 2004 · Journal of Biological Chemistry
69. Inverse and distinct modulation of tau‐dependent neurodegeneration by presenilin 1 and amyloid‐β in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid‐β‐induced cell death
    Julia Leschik, Alfred T. Welzel, Carina Weissmann, Anne Eckert, Roland Brandt · 2007 · Journal of Neurochemistry
70. Alzheimer's Disease-like Alterations in Peripheral Cells from Presenilin-1 Transgenic Mice
    Anne Eckert, Katharina Schindowski, Silke Leutner, Christian Luckhaus, Nathalie Touchet, Christian Czech, Walter E. Müller · 2001 · Neurobiology of Disease
71. Reduction of calcium release from the endoplasmic reticulum could only provide partial neuroprotection against beta‐amyloid peptide toxicity
    Ka‐Chun Suen, Kim‐Fung Lin, Wassim Elyaman, Kwok‐Fai So, Raymond Chuen‐Chung Chang, Jacques Hugon · 2003 · Journal of Neurochemistry
72. Pro‐apoptotic effect of presenilin 2 (PS2) overexpression is associated with down‐regulation of Bcl‐2 in cultured neurons
    Wataru Araki, Katsutoshi Yuasa, Shin'ichi Takeda, Kazuya Takeda, Keiro Shirotani, Keikichi Takahashi, Takeshi Tabira · 2001 · Journal of Neurochemistry
73. Molecular Mechanisms for Neuronal Cell Death by Alzheimer’s Amyloid Precursor Protein-Relevant Insults
    Masaoki Kawasumi, Yuichi Hashimoto, Tomohiro Chiba, Kohsuke Kanekura, Yohichi Yamagishi, Miho Ishizaka, Hirohisa Tajima, Takako Niikura, Ikuo Nishimoto · 2002 · Neurosignals
74. Transgenic mice expressing the PS1-A246E mutation: effects on spatial learning, exploration, anxiety, and motor coordination
    Robert Lalonde, Sue Qian, C. Strazielle · 2002 · Behavioural Brain Research
75. Enhanced generation of intracellular Aβ42 amyloid peptide by mutation of presenilins PS1 and PS2
    Kazuya Takeda, Wataru Araki, Takeshi Tabira · 2004 · European Journal of Neuroscience
76. Viral-based gene transfer to the mammalian CNS for functional genomic studies
    Christopher G. Janson, Scott McPhee, Paola Leone, Andrew B. Freese, Matthew J. During · 2001 · Trends in Neurosciences
77. Animal Models in Biomedical Research
    Kirk J. Maurer, Fred William Quimby · 2015 · Elsevier eBooks
78. Searching for new animal models of Alzheimer′s disease
    Roberta Epis, Fabrizio Gardoni, Elena E. Marcello, Armando A. Genazzani, Pier Luigi Canonico, Mónica Di Luca · 2009 · European Journal of Pharmacology
79. Stem Cell Therapy for Alzheimer's Disease.
    F. Han, Jian-Zhong Bi, Li-Yan Qiao, O. Arancio · 2020 · Advances in Experimental Medicine and Biology
80. Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer’s disease Mouse Brain
    Fang Du, Zhihua Zhang, Hang Li, Qing Yu, Justin T. Douglas, Anna Bratasz, Periannan Kuppusamy, Shirley ShiDu Yan · 2016 · Journal of Alzheimer s Disease
81. Mitochondrial Perturbation in Alzheimer's Disease and Diabetes
    Firoz Akhter, Doris Chen, S.F. Yan, S.S. Yan · 2017 · Progress in molecular biology and translational science
82. Formic acid is essential for immunohistochemical detection of aggregated intraneuronal Aβ peptides in mouse models of Alzheimer's disease
    Christensen, Ditte Z., Bayer, Thomas A., Wirths, Oliver · 2009 · Brain Research
83. Functional and morphological alterations in compound transgenic mice overexpreszing Cu/Zn superoxide dismutaze and amyloid precursor protein
    Catherine Harris‐Cerruti, Ariel Kamsler, Batia Kaplan, Bruce T. Lamb, Menahem Segal, Yoram Groner · 2004 · European Journal of Neuroscience
84. Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically
    Mariagrazia Grilli, Enrica Diodato, Gianluca Lozza, R. Brusa, María Jesús Casarini, Daniela Letizia Uberti, Richard F. Rozmahel, David A. Westaway, Peter St George‐Hyslop, Maurizio Memo et al. · 2000 · Proceedings of the National Academy of Sciences
85. Loss of presenilin function causes Alzheimer's disease‐like neurodegeneration in the mouse
    Qian Chen, Akira Nakajima, Se Hoon Choi, Xiaoli Xiong, Ya‐Ping Tang · 2008 · Journal of Neuroscience Research
86. Characteristic developmental expression of amyloid β40, 42 and 43 in patients with Down syndrome
    Aya Hirayama, Yuko Horikoshi, Masahiro Maeda, Masayuki Ito, Sachio Takashima · 2003 · Brain and Development
87. Pael receptor is involved in dopamine metabolism in the nigrostriatal system
    Yuzuru Imai, Haruhisa Inoue, Ayane Kataoka, Hua‐Qin Wang, Masao Masuda, Toshio Ikeda, Kayoko Tsukita, Mariko Soda, Tohru Kodama, Tatsu Fuwa et al. · 2007 · Neuroscience Research
88. Curcumin protects against intracellular amyloid toxicity in rat primary neurons.
    Jelina Ye, Yan Zhang · 2012 · Europe PMC (PubMed Central)
89. Gene-Environment Interaction Research and Transgenic Mouse Models of Alzheimer's Disease (Erratum)
    Leonidas Chouliaras, Annerieke S. R. Sierksma, Günter Kenis, Jos Prickaerts, Marijke A.M. Lemmens, Ivona Brasnjevic, Eva L. van Donkelaar, Pilar Martínez‐Martínez, Mario H. Losen, Marc H. De Baets et al. · 2010 · International Journal of Alzheimer s Disease
90. Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology
    Suelves, Nuria, Saleki, Shirine, Ibrahim, Tasha, Palomares, Debora, Moonen, Sebastiaan, Koper, Marta J., Vrancx, Céline, Vadukul, Devkee M., Papadopoulos, Nicolas, Viceconte, Nikenza et al. · 2023 · Acta Neuropathologica Communications
91. A pharmacogenomic approach to Alzheimer’s disease
    Ramón Cacabelos, Antón Álvarez, L. Fernández‐Novoa, Valter Lombardi · 2000 · Acta Neurologica Scandinavica
92. Early life nutrient restriction impairs blood–brain metabolic profile and neurobehavior predisposing to Alzheimer’s disease with aging
    Masatoshi Tomi, Yuanzi Zhao, Shanthie Thamotharan, Bo‐Chul Shin, Sherin U. Devaskar · 2012 · Brain Research
93. Regional brain metabolism with cytochrome c oxidase histochemistry in a PS1/A246E mouse model of autosomal dominant Alzheimer's disease: Correlations with behavior and oxidative stress
    C. Strazielle, Rozat Jazi, Yann Verdier, Sue Qian, Robert Lalonde · 2009 · Neurochemistry International
94. γ-Secretase Cleavage Site Specificity Differs for Intracellular and Secretory Amyloid β
    Heike S. Grimm, Dirk Beher, Stefan F. Lichtenthaler, Mark S. Shearman, Konrad T. Beyreuther, Tobias Hartmann · 2003 · Journal of Biological Chemistry
95. Overview of Chinese research on senile dementia in mainland China
    Yuetao Song, Jintang Wang · 2010 · Ageing Research Reviews
96. Intracellular Amyloid β-Protein As a Therapeutic Target for Treating Alzheimers Disease
    Yasumasa Ohyagi · 2008 · Current Alzheimer Research
97. New developments in animal models of Alzheimer’s disease
    Christopher Janus, Amie L. Phinney, Muhammad Azhar Chishti, David A. Westaway · 2001 · Current Neurology and Neuroscience Reports
98. Association of ApoE and LRP mRNA levels with dementia and AD neuropathology
    Afia Muhammad Akram, James Schmeidler, Pavel Katsel, Patrick R. Hof, Vahram H. Haroutunian · 2011 · Neurobiology of Aging
99. Overexpression of Presenilin‐2 Enhances Apoptotic Death of Cultured Cortical Neurons
    Wataru Araki, Katsutoshi Yuasa, Shin’ichi Takeda, Keiro Shirotani, Keikichi Takahashi, Takeshi Tabira · 2000 · Annals of the New York Academy of Sciences
100. Up-regulation of Bcl-xL in response to subtoxic β-amyloid: role in neuronal resistance against apoptotic and oxidative injury
     Craig Marc Luetjens, Silke Lankiewicz, Nguyen Truc Bui, Aaron J. Krohn, Monika Poppe, Jochen H.M. Prehn · 2001 · Neuroscience